ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Citigroup Cuts Targets Across the Board

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Citigroup dominated analyst activity on Tuesday, slashing price targets across multiple sectors in a sweep that signals broad caution from the bank's research desk.

AppLovin took the biggest hit in absolute dollar terms. Citi analyst Jason Bazinet cut his target from $600 to $500, a $100 drop, while holding his Buy rating. The ad-tech firm carries a market cap of $81 billion and short interest of just 4% of free float, so bears are not piling in yet.

Oilfield services names also felt the knife. Citi's Scott Gruber trimmed targets on both SLB and Baker Hughes. SLB moved from $63 to $62, Baker Hughes from $75 to $72. Both remain Buy-rated. The broader SLB consensus target also edged up slightly to $62.41, suggesting other banks are more upbeat.

JP Morgan added to the pressure on Xylem, cutting its target sharply from $137 to $118. That is a 14% reduction. The water technology firm's Hold rating was unchanged.

PNC Financial and Bank of New York Mellon both saw Citi's Benjamin Gerlinger trim targets. PNC fell from $290 to $270. BNY dropped from $160 to $157.

The one bright spot came from logistics. Prologis was upgraded to Buy at the consensus level, with the average target rising from $152.85 to $155.85. The $120 billion warehouse giant has short interest below 2% of free float, a sign the market is not betting against the rebound thesis.

Gilead Sciences saw its consensus target trimmed slightly to $159.20 from $159.85, with 21 Buy ratings still in place.

Stocks in this article

How this article was generated

Generated
20 Oct 2026, 04:21
Prompt version
v1.0
Data sources
Analyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.